Lyell Immunopharma, Inc. (LYEL)
32.11
-0.53
(-1.62%)
USD |
NASDAQ |
Dec 17, 16:00
32.11
0.00 (0.00%)
After-Hours: 20:00
Lyell Immunopharma EPS Diluted (Quarterly): -2.126 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | -0.805 |
| AnaptysBio, Inc. | 0.5208 |
| Ovid Therapeutics, Inc. | -0.171 |
| Cogent Biosciences, Inc. | -0.5884 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -38.85M |
| Revenue (Quarterly) | 0.015M |
| Total Expenses (Quarterly) | 38.86M |
| Enterprise Value | 216.79M |
| Gross Profit Margin (Quarterly) | -17.01K% |
| Profit Margin (Quarterly) | -259.0K% |
| Earnings Yield | -61.01% |
| Normalized Earnings Yield | -37.39 |